Takeda Pharmaceuticals International AG's Net Worth

$139 Million

Estimate Recalculated Sep 8, 2024 07:19PM EST

Who is Takeda Pharmaceuticals International AG?

Takeda Pharmaceuticals International AG has an estimated net worth of $139 Million. This is based on reported shares across multiple companies, which include Cortexyme, Inc., Molecular Templates, Inc., and Myovant Sciences Ltd..

SEC CIK

Takeda Pharmaceuticals International AG's CIK is 0001688140

Past Insider Trading and Trends

2017 was Takeda Pharmaceuticals International AG's most active year for acquiring shares with 4 total transactions. Takeda Pharmaceuticals International AG's most active month to acquire stocks was the month of December. 2017 was Takeda Pharmaceuticals International AG's most active year for disposing of shares, totalling 4 transactions. Takeda Pharmaceuticals International AG's most active month to dispose stocks was the month of February. 2016 saw Takeda Pharmaceuticals International AG paying a total of $0.00 for 1,999,410 shares, this is the most they've acquired in one year. In 2018 Takeda Pharmaceuticals International AG cashed out on 7,420,625 shares for a total of $138,543,068.75, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cortexyme, Inc. (QNCX) Snapshot price: $0.71

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.68M
—
—
2.68M
May 13
Form 3
—
0
—
—
0
No matching records found

Molecular Templates, Inc. (MTEM) Snapshot price: $1.53

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Myovant Sciences Ltd. No price found

Investor

Takeda Pharmaceuticals International AG owns 7,420,625 units of Common Shares. Takeda Pharmaceuticals International AG used to own units in Common Stock but no longer holds any shares there. From 2016 to 2018 Takeda Pharmaceuticals International AG acquired a total of 2,029,505 shares in Myovant Sciences Ltd., Takeda also disposed a total of 7,420,625 shares of Myovant Sciences Ltd. equalling to $138,543,068.75.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$18.67
—
7.42M
Mar 19
Form 4
+0.06%
4.43K
—
—
7.42M
Apr 17
Form 4
+0.27%
19.94K
—
—
7.42M
Feb 15 - Mar 15
Form 4
+0.38%
27.87K
—
—
7.4M
Dec 15 - Jan 17
Form 4
+36.68%
1.98M
—
—
7.37M
Nov 1
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found